Latest Macula Stories
Smoking is already a known risk factor for age-related macular degeneration, cataract and thyroid eye disease.
Scientists discover the relationship between 2 blood proteins plays a pivotal role in staving off the condition.
University of Iowa researchers have found the existence of a new, rare inherited retinal disease.
LEUVEN, Belgium, December 11 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD). Wet AMD affects approximately five million patients worldwide and this patient population is continuing to grow.
BIRMINGHAM, Ala., Dec. 2 /PRNewswire/ -- Adults are more likely to lose their vision than be diagnosed with cancer.
Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach other cells at a distance, the retina shows defects similar to "dry" macular degeneration, also called geographic atrophy (GA).
Discovery may also have impact on the use of new drugs for wet macular degeneration BOSTON, Nov. 2 /PRNewswire-USNewswire/ -- Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e.
ORLANDO, Fla., Oct.
PARIS, Oct. 1 /PRNewswire/ -- Fovea Pharmaceuticals announced today that it has entered into a binding agreement with sanofi-aventis to sell 100% of its share to sanofi-aventis.
Sponsored by Delaware Valley Retina Associates and the Macula Vision Research Foundation WEST CONSHOHOCKEN, Pa., Sept.
More Images (2 images) »